Gentile A T, Moneta G L, Taylor L M, Park T C, McConnell D B, Porter J M
Department of Surgery, Oregon Health Sciences University, Portland.
Arch Surg. 1994 Sep;129(9):926-31; discussion 931-2. doi: 10.1001/archsurg.1994.01420330040009.
A number of reports indicate revascularization for intestinal ischemia should include the superior mesenteric artery (SMA) and the celiac artery. However, no controlled or randomized studies have proven this approach superior to SMA bypass alone. We report our results using bypass to only the SMA for intestinal ischemia.
Retrospective review with mean follow-up of 40 months (range, 2 to 110 months).
University medical center and Veterans Affairs hospital.
PATIENTS/METHODS: The records of patients who underwent intestinal revascularization of the SMA alone from 1982 through 1993 were reviewed. Patients were assessed for indication for operation, operative technique, perioperative mortality, and long-term outcome. The SMA grafts were examined for patency within the last 6 months using duplex scanning or arteriography. Patient survival and graft patency rates were calculated using life-table methods.
Twenty-nine bypasses to only the SMA were performed in 26 patients (16 female and 10 male; mean age, 59 years; age range, 13 to 81 years). Indication for operation was symptomatic chronic mesenteric ischemia in 23 cases and acute intestinal ischemia in five cases. One bypass was performed for asymptomatic SMA occlusion. There were three perioperative deaths (10% mortality rate), all in patients with acute intestinal ischemia and previous mesenteric arterial surgery. Life-table 4-year primary graft patency and patient survival rates were 89% and 82%, respectively. Symptomatic improvement was maintained in all patients available for follow-up.
Revascularization of only the SMA for intestinal ischemia provides excellent graft patency with acceptable perioperative mortality and long-term patient survival. The SMA bypass alone for intestinal ischemia appears as successful as bypasses to multiple visceral vessels.
多项报告表明,肠道缺血的血运重建应包括肠系膜上动脉(SMA)和腹腔干。然而,尚无对照或随机研究证明这种方法优于单纯的SMA旁路手术。我们报告了仅对SMA进行旁路手术治疗肠道缺血的结果。
回顾性研究,平均随访40个月(范围为2至110个月)。
大学医学中心和退伍军人事务医院。
患者/方法:回顾了1982年至1993年期间仅接受SMA肠道血运重建的患者记录。评估患者的手术指征、手术技术、围手术期死亡率和长期预后。使用双功扫描或动脉造影检查SMA移植物在过去6个月内的通畅情况。采用寿命表法计算患者生存率和移植物通畅率。
26例患者(16例女性和10例男性;平均年龄59岁;年龄范围13至81岁)接受了仅针对SMA的29次旁路手术。手术指征为23例有症状的慢性肠系膜缺血和5例急性肠道缺血。1例因无症状的SMA闭塞而进行旁路手术。围手术期死亡3例(死亡率10%),均为急性肠道缺血且既往有肠系膜动脉手术史的患者。寿命表法显示4年原发性移植物通畅率和患者生存率分别为89%和82%。所有接受随访的患者症状均持续改善。
仅对SMA进行肠道缺血血运重建可提供良好的移植物通畅率,围手术期死亡率可接受,患者长期生存率较高。仅对SMA进行旁路手术治疗肠道缺血似乎与对多个内脏血管进行旁路手术一样成功。